19-10961203-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS1
The NM_003072.5(SMARCA4):c.-32+29C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00175 in 146,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SMARCA4
NM_003072.5 intron
NM_003072.5 intron
Scores
1
1
Clinical Significance
Conservation
PhyloP100: -0.0760
Publications
0 publications found
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 19-10961203-C-T is Benign according to our data. Variant chr19-10961203-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 1694888.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00175 (257/146862) while in subpopulation NFE AF = 0.00283 (187/66064). AF 95% confidence interval is 0.0025. There are 0 homozygotes in GnomAd4. There are 109 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.-29+29C>T | intron_variant | Intron 1 of 35 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.-32+29C>T | intron_variant | Intron 1 of 34 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.-29+29C>T | intron_variant | Intron 1 of 34 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.-192+29C>T | intron_variant | Intron 1 of 34 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.-32+29C>T | intron_variant | Intron 1 of 33 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.-29+29C>T | intron_variant | Intron 1 of 33 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.-261+29C>T | intron_variant | Intron 1 of 34 | 5 | ENSP00000464778.1 |
Frequencies
GnomAD3 genomes AF: 0.00175 AC: 257AN: 146752Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
257
AN:
146752
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 54Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 28
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
54
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
28
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
0
AN:
28
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
26
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome AF: 0.00175 AC: 257AN: 146862Hom.: 0 Cov.: 31 AF XY: 0.00152 AC XY: 109AN XY: 71614 show subpopulations
GnomAD4 genome
AF:
AC:
257
AN:
146862
Hom.:
Cov.:
31
AF XY:
AC XY:
109
AN XY:
71614
show subpopulations
African (AFR)
AF:
AC:
23
AN:
40364
American (AMR)
AF:
AC:
36
AN:
14918
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3394
East Asian (EAS)
AF:
AC:
0
AN:
4910
South Asian (SAS)
AF:
AC:
7
AN:
4702
European-Finnish (FIN)
AF:
AC:
2
AN:
9332
Middle Eastern (MID)
AF:
AC:
0
AN:
264
European-Non Finnish (NFE)
AF:
AC:
187
AN:
66064
Other (OTH)
AF:
AC:
2
AN:
2044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
SMARCA4: BS1 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.